Immune Design (IMDZ) Tops Q1 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Cowen Starts Immune Design (IMDZ) at Outperform
May 15, 2015 7:04 AM EDTCowen initiated coverage on Immune Design (NASDAQ: IMDZ) with an Outperform rating.
For an analyst ratings summary and ratings history on Immune Design click here. For more ratings news on Immune Design click here.
Shares of Immune Design closed at $21.29 yesterday.
... More